Hormonal therapy for breast cancer. An update.
The use of endocrine manipulation for the treatment of breast cancer has been available for 100 years, but in recent years the number of therapeutic options available to patients has increased dramatically. This article considers new developments in the use of hormonal agents for the treatment and prevention of breast cancer.
Gradishar
W J
WJ
Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School, Chicago, Illinois, USA.
Jordan
V C
VC
D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D004703:Endocrine System / Q000378:metabolism* / Q000503:physiopathology; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D011372:Progestins / Q000627:therapeutic use
D047072:Aromatase Inhibitors; D004791:Enzyme Inhibitors; D004965:Estrogen Antagonists; D011372:Progestins; D007987:Gonadotropin-Releasing Hormone